Bioavailability & Bioequivalence


Bioavailability & Bioequivalence (BA/BE) Studies

Genecht Research operates a state-of-the-art 100-bed Clinical Research Facility designed to support a wide spectrum of Bioequivalence studies. Our facility features dedicated male and female housing units, a fully equipped emergency care and medical support unit, and a standalone bioanalytical laboratory equipped with 06 high-sensitivity LC-MS/MS Instruments to ensure accurate, reliable, and regulatory-compliant data generation.

With integrated clinical and bioanalytical operations under one roof, we deliver efficient study execution while maintaining the highest standards of participant safety, quality, and scientific integrity

Clinical Research Capabilities

  • Single-Dose BA/BE Studies
    • Fasting Studies
    • Fed Studies
    • Sprinkle Administration (e.g., Applesauce-Based Studies)
  • Multiple-Dose BA/BE Studies
    • Fasting Conditions
    • Fed Conditions
  • Steady-State Pharmacokinetic Studies
  • Partial Replicate & Full Replicate Study Designs
  • Parallel Design BA/BE Studies
  • Truncated BA/BE Studies
  • BA/BE Studies for Controlled & Psychotropic Substances
  • Long-Term Housing & Extended Confinement Studies

Specialized Pharmacokinetic & Clinical Research Studies

Leveraging our scientific expertise and advanced infrastructure, Genecht Research supports complex and specialized clinical development programs, including: